Beta2-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men
暂无分享,去创建一个
V. Backer | J. Bangsbo | G. Jacobson | S. Jessen | M. Hostrup | A. Kalsen | J. Onslev | M. Kreiberg | C. Narkowicz
[1] Jacob Cohen. Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.
[2] G. Jacobson,et al. Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control. , 2017, Drug testing and analysis.
[3] M. Gillum,et al. Towards Leanness by ‘Feeding’ a Novel Thermogenic Pathway? , 2016, Trends in Endocrinology & Metabolism.
[4] V. Backer,et al. Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men , 2016, Front. Pharmacol..
[5] V. Backer,et al. Effect of formoterol, a long-acting β2-adrenergic agonist, on muscle strength and power output, metabolism, and fatigue during maximal sprinting in men. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.
[6] M. Scherrer-Crosbie,et al. Relationship of brown adipose tissue perfusion and function: a study through β2-adrenoreceptor stimulation. , 2016, Journal of applied physiology.
[7] V. Backer,et al. Mechanisms underlying enhancements in muscle force and power output during maximal cycle ergometer exercise induced by chronic β2-adrenergic stimulation in men. , 2015, Journal of applied physiology.
[8] R. Wood‐Baker,et al. SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: are some athletes at risk of higher urine levels? , 2015, Drug testing and analysis.
[9] V. Backer,et al. β2‐Adrenergic stimulation enhances Ca2+ release and contractile properties of skeletal muscles, and counteracts exercise‐induced reductions in Na+–K+‐ATPase Vmax in trained men , 2014, The Journal of physiology.
[10] V. Backer,et al. Effect of inhaled terbutaline on substrate utilization and 300-kcal time trial performance. , 2014, Journal of applied physiology.
[11] Alan D. Lopez,et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.
[12] G. Jacobson,et al. Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle. , 2014, Drug testing and analysis.
[13] W. D. van Marken Lichtenbelt,et al. Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: a prospective, case-controlled observational study. , 2014, The lancet. Diabetes & endocrinology.
[14] J. Greenfield,et al. Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men , 2013, International Journal of Obesity.
[15] W. D. van Marken Lichtenbelt,et al. Systemic β-Adrenergic Stimulation of Thermogenesis Is Not Accompanied by Brown Adipose Tissue Activity in Humans , 2012, Diabetes.
[16] V. Backer,et al. Urine and Serum Concentrations of Inhaled and Oral Terbutaline , 2012, International Journal of Sports Medicine.
[17] J. Baker,et al. The selectivity of β‐adrenoceptor agonists at human β1‐, β2‐ and β3‐adrenoceptors , 2010, British journal of pharmacology.
[18] B. Waldeck,et al. Further Studies on the Cardiomegaly Induced by β‐Adrenoceptor Agonists , 2009 .
[19] E. Kerwin,et al. Nebulized formoterol fumarate: Dose selection and pharmacokinetics. , 2008, Pulmonary pharmacology & therapeutics.
[20] W. Saris,et al. Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects , 2008, Diabetes.
[21] A. Tattersfield,et al. Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study. , 2008, British journal of clinical pharmacology.
[22] W. Saris,et al. HSL serine phosphorylation and glycerol exchange across skeletal muscle in lean and obese subjects: effect of beta-adrenergic stimulation , 2008 .
[23] G. Lynch,et al. Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. , 2008, Physiological reviews.
[24] D. Goldspink,et al. Relative myotoxic and haemodynamic effects of the β‐agonists fenoterol and clenbuterol measured in conscious unrestrained rats , 2006, Experimental physiology.
[25] M. Sillence,et al. Systemic administration of β2‐adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses , 2006, British journal of pharmacology.
[26] M. Sillence,et al. Chronic β-agonist administration affects cardiac function of adult but not old rats, independent of β-adrenoceptor density , 2005 .
[27] M. Sillence,et al. Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor density. , 2005, American journal of physiology. Heart and circulatory physiology.
[28] W. Saris,et al. Impaired β-adrenergically mediated lipolysis in skeletal muscle of obese subjects , 2004, Diabetologia.
[29] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[31] Glen P Kenny,et al. Effect of cold exposure on fuel utilization in humans: plasma glucose, muscle glycogen, and lipids. , 2002, Journal of applied physiology.
[32] A. Medvedev,et al. β-Adrenergic Activation of p38 MAP Kinase in Adipocytes , 2001, The Journal of Biological Chemistry.
[33] W. Saris,et al. beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. , 2001, The Journal of clinical endocrinology and metabolism.
[34] G. Cheymol. Effects of Obesity on Pharmacokinetics , 2000 .
[35] H. Magnussen,et al. The effect of the enantiomers of formoterol on inherent and induced tone in guinea-pig trachea and human bronchus , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[36] M. Palmisano,et al. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer. , 1999, European journal of clinical pharmacology.
[37] Michael G. M. Derks,et al. Biphasic effect-time courses in man after formoterol inhalation: eosinopenic and hypokalemic effects and inhibition of allergic skin reactions. , 1997, The Journal of pharmacology and experimental therapeutics.
[38] F. Hulot,et al. Effect of clenbuterol on productive performance, body composition and muscle biochemistry in the rabbit. , 1996, Meat science.
[39] B. Waldeck,et al. Steric aspects of formoterol and terbutaline: is there an adverse effect of the distomer on airway smooth muscle function? , 1996, Chirality.
[40] A. Astrup. The sympathetic nervous system as a target for intervention in obesity. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[41] P. J. Randle,et al. Metabolic fuel selection: general integration at the whole-body level , 1995, Proceedings of the Nutrition Society.
[42] H. A. Dahl,et al. Adrenaline stimulated glycogen breakdown in rat epitrochlearis muscles: fibre type specificity and relation to phosphorylase transformation. , 1995, Biochemistry and molecular biology international.
[43] J. Port,et al. Age‐Related Changes in β‐Adrenergic Neuroeffector Systems in the Human Heart , 1994, Circulation.
[44] J. Suko,et al. Phosphorylation of serine 2843 in ryanodine receptor-calcium release channel of skeletal muscle by cAMP-, cGMP- and CaM-dependent protein kinase. , 1993, Biochimica et biophysica acta.
[45] C. Löfdahl,et al. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration. , 1989, Allergy.
[46] Portland Press Ltd. Palmitate inhibits liver glycolysis. Involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle , 1988 .
[47] E. Ferrannini. The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.
[48] B. Waldeck,et al. Further studies on the cardiomegaly induced by beta-adrenoceptor agonists. , 1986, Acta pharmacologica et toxicologica.
[49] N. Rothwell,et al. Chronic effects of β2 agonists on body composition and protein synthesis in the rat , 1984, Bioscience reports.
[50] T. Clausen,et al. β2‐ADRENOCEPTORS MEDIATE THE STIMULATING EFFECT OF ADRENALINE ON ACTIVE ELECTROGENIC NA‐K‐TRANSPORT IN RAT SOLEUS MUSCLE , 1980 .
[51] T. Clausen,et al. Beta 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscle. , 1980, British journal of pharmacology.
[52] J. Kjekshus,et al. The Effect of Free Fatty Acids on Myocardial Oxygen Consumption During Atrial Pacing and Catecholamine Infusion in Man , 1978, Circulation.
[53] P. J. Randle. The Interrelationships of Hormones, Fatty Acid and Glucose in the Provision of Energy , 1964, Postgraduate medical journal.
[54] E. Newsholme,et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.